Prevest Denpro Ltd

AI
Prevest Denpro Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Prevest Denpro Ltd

₹ 408 4.72%
16 Oct - close price
prevestdenpro.com BSE - SME: 543363
About

Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.

Key Points

Product Portfolio[1]
The company offers over 100 dental products across:
a) Restorative Materials:
Cavity restoration solutions.
b) Endodontic Solutions:
Root canal treatment
materials.
c) Preventive Care:
Post-extraction and decay
prevention products.
d) Orthodontic Adhesives:
Bonding solutions for braces
and aligners.
e) Impression Materials & Cements:
Impression and cementation products.

Website BSE
  • Market Cap ₹ 490 Cr.
  • Current Price ₹ 408
  • High / Low ₹ 550 / 318
  • Stock P/E 22.6
  • Book Value ₹ 104
  • Dividend Yield 0.24 %
  • ROCE 24.2 %
  • ROE 17.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
13.39 13.18 13.62 16.24 13.36 16.27 14.95 18.45 15.77 18.64 18.46 18.94 19.07
8.43 8.77 9.14 10.24 8.84 10.46 9.74 11.91 10.46 11.96 12.66 12.03 12.31
Operating Profit 4.96 4.41 4.48 6.00 4.52 5.81 5.21 6.54 5.31 6.68 5.80 6.91 6.76
OPM % 37.04% 33.46% 32.89% 36.95% 33.83% 35.71% 34.85% 35.45% 33.67% 35.84% 31.42% 36.48% 35.45%
0.61 0.74 0.68 0.84 0.86 1.04 1.09 1.08 1.17 1.19 1.15 1.41 1.32
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.17 0.22 0.42 0.46 0.48 0.47 0.48 0.47 0.49 0.50 0.51 0.51 0.52
Profit before tax 5.40 4.93 4.74 6.38 4.90 6.38 5.82 7.15 5.99 7.37 6.44 7.81 7.56
Tax % 24.26% 26.17% 23.21% 25.08% 25.10% 24.61% 22.16% 28.11% 26.38% 24.83% 26.71% 25.48% 25.40%
4.08 3.64 3.64 4.77 3.67 4.82 4.53 5.14 4.41 5.54 4.72 5.82 5.64
EPS in Rs 3.40 3.03 3.03 3.97 3.06 4.02 3.77 4.28 3.67 4.62 3.93 4.85 4.70
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026 TTM
56 63 72 75
36 41 47 49
Operating Profit 20 22 25 26
OPM % 36% 35% 35% 35%
3 4 5 5
Interest 0 0 0 0
Depreciation 1 2 2 2
Profit before tax 21 24 28 29
Tax % 25% 25% 26%
16 18 20 22
EPS in Rs 13.45 15.13 17.07 18.10
Dividend Payout % 7% 7% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 15%
Stock Price CAGR
10 Years: %
5 Years: 8%
3 Years: -3%
1 Year: -21%
Return on Equity
10 Years: %
5 Years: %
3 Years: 18%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
Equity Capital 12 12 12
Reserves 77 94 113
0 0 0
6 7 8
Total Liabilities 95 113 133
27 27 27
CWIP 0 0 0
Investments 2 5 9
66 81 98
Total Assets 95 113 133

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 Mar 2026
12 15 15
-2 -1 -2
-0 -1 -1
Net Cash Flow 10 12 12
Free Cash Flow 8 13 13
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 81% 93% 86%

Ratios

Consolidated / View Standalone

Mar 2024 Mar 2025 Mar 2026
Debtor Days 53 44 44
Inventory Days 168 214 239
Days Payable 32 43 55
Cash Conversion Cycle 189 215 229
Working Capital Days 79 82 91
ROCE % 25% 24%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Countries Exported To
Countries (approx.)

Log in to view insights

Please log in to see hidden values.

Login
Number of Dealers in India
Dealers (approx.)
Number of Overseas Agents
Overseas Agents (approx.)
Capacity Utilization
%
Installed Capacity
MT per annum
Number of Permanent Employees
Employees
Domestic Revenue Share
% of Revenue from Operations
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60%
0.31% 0.52% 1.11% 0.63% 0.63% 0.63% 0.63% 0.63% 0.65% 0.65% 0.65% 0.65%
0.68% 0.68% 0.68% 0.68% 0.71% 1.28% 1.22% 0.75% 0.77% 0.77% 0.79% 0.79%
25.40% 25.20% 24.61% 25.09% 25.07% 24.49% 24.54% 25.01% 24.97% 24.97% 24.94% 24.94%
No. of Shareholders 2,0401,9911,8961,8221,8321,8871,9281,8881,9571,9601,9751,994

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls